BLOG

Tuesday, September 4, 2018

Anti-inflammatory use during surgery could improve cancer outcomes

The world's first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve their cancer outcome.

from Top Health News -- ScienceDaily https://ift.tt/2CjkSyG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...